Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.1700 (-3.91%) ($11.1700 - $11.1700) on Mon. May. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.98% (three month average) | RSI | 71 | Latest Price | $11.1700(-3.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 4.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(37%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -2.49% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-1%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.49% (StdDev 4.98%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $11.22 | 5 Day Moving Average | $11.92(-6.29%) | 10 Day Moving Average | $11.91(-6.21%) | 20 Day Moving Average | $11.22(-0.45%) | To recent high | -18% | To recent low | 21.5% | Market Cap | $1.971b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |